Opposite effects of GABA(B) receptor antagonists on absences and convulsive seizures

European Journal of Pharmacology

Volumn 332, Issue 3, 1997, Pages 245-255

  Vergnes, Marguerite ^a   Boehrer, Anny ^a   Simler, Simone ^a   Bernasconi, Raymond ^a   Marescaux, Christian ^a  

^a INSERM   (France)

Author keywords

c Fos; Cortex; Epilepsy; GABA(B) receptor antagonist; Hippocampus; Thalumus

Indexed keywords

3 AMINOPROPYLBUTYLPHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; [3 [1 (3 CARBOXYPHENYL)ETHYLAMINO] 2 HYDROXYPROPYL]CYCLOHEXYLMETHYLPHOSPHINIC ACID; BACLOFEN; PROTEIN C FOS; UNCLASSIFIED DRUG; (3 AMINOPROPYL)(N BUTYL)PHOSPHINIC ACID; (3-AMINOPROPYL)(N-BUTYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; CGP 56999A; ORGANOPHOSPHORUS COMPOUND; PHOSPHINIC ACID DERIVATIVE;

ABSENCE; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN REGION; CLONIC SEIZURE; CONTROLLED STUDY; DOSE RESPONSE; FOCAL EPILEPSY; INTRACEREBRAL DRUG ADMINISTRATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIMBIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; THALAMUS; ANIMAL; BIOSYNTHESIS; BRAIN; DRUG ANTAGONISM; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; BRAIN; EPILEPSY, ABSENCE; GABA ANTAGONISTS; MALE; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHINIC ACIDS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RECEPTORS, GABA-B; SEIZURES;

EID: 0030609959     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01085-6     Document Type: Article

References (53)

1. B receptors. Eur. J. Pharmacol. 218:1992;137-143.
2. Ault B., Nadler J.V. Anticonvulsant like actions of baclofen in the rat hippocampal slice. Br. J. Pharmacol. 78:1983;701-708.
3. Avoli, M., Gloor, P., 1994. Physiopathogenesis of feline generalized penicillin epilepsy: The role of thalamocortical mechanisms. In: Malafosse, A., Genton, P., Hirsch, E., Marescaux, C., Broglin, D., Bernasconi, R. (Eds.), Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. John Libbbey, London, pp. 111-121.
4. B) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): A possible mechanism for the generation of absence-like seizures induced by GHB. J. Pharmac. Exp. Ther. 273:1995;1534-1543.
5. B antagonists: Potential new drugs. Pharmacol. Commun. 2:1992;70-74.
6. B receptor antagonists: From synthesis to therapeutic applications. TIPS. 14:1993;391-394.
7. B receptor subtypes in the rat cerebral cortex. J. Pharmac. Exp. Ther. 262:1992;114-118.
8. Bonanno G., Raiteri M. Multiple GABA B receptors. TIPS. 14:1993;259-261.
9. Bowery N.G. GABAB receptor pharmacology. Ann. Rev. Pharmacol. Toxicol. 33:1993;109-147.
10. B receptors as targets for drug action. Arzneim. Forsch./Drug Res. 42:1992;215-223.
11. Browning, R.A., 1994. Anatomy of generalized convulsive seizures. In: Malafosse, A., Genton, P., Hirsch, E., Marescaux, C., Broglin, D., Bernasconi, R. (Eds.), Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. John Libbbey, London, pp. 399-413.
12. Coulter, D.A., Zhang, Y., 1994. Thalamocortical rhythm generation in vitro: physiological mechansims, pharmacological control, and relevance to generalized absence epilepsy. In: Malafosse, A., Genton, P., Hirsch, E., Marescaux, C., Broglin, D., Bernasconi, R. (Eds.), Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. John Libbbey, London, pp. 123-131.
13. B receptors in excitation and inhibition of thalamocortical cells. Trends Neurosci. 14:1991;16-21.
14. B IPSP-mediated oscillations of thalamic neurons in absence epilepsy. In: Malafosse, A., Genton, P., Hirsch, E., Marescaux, C., Broglin, D., Bernasconi, R. (Eds.), Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. John Libbbey, London, pp. 201-213.
15. Crunelli V., Fricker D., Le Feuvre Y., Emri Z., Turner J.P., Williams S.R., Leresche N. Presynaptic GABA B receptors on GABA and glutamate containing afferents in the thalamus. Pharmacol. Rev. Commun. 8:1996;107-110.
16. B receptors of rat neocortical neurons differ in their pharmacological properties. Neurosci. Lett. 154:1993;209-212.
17. Dragunow M., Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci. Methods. 29:1989;261-265.
18. B receptors in the central nervous system. Nature. 332:1988;156-158.
19. Faingold C.L., Marcinczyk M.J., Casebeer D.J., Randall M.E., Arneric S.P., Browning R.A. GABA in the inferior colliculus plays a critical role in control of audiogenic seizures. Brain Res. 640:1994;40-47.
20. B antagonists. Pharmacol. Commun. 2:1992;52-56.
21. B sites in rat brain Nature. 290:1981;149-152.
22. Hirsch, E., Vergnes, M., Simler, S., Maton, B., Nehlig, A., Marescaux, C., 1994. Propagation of generalized seizures from brain-stem to forebrain networks. In: Malafosse, A., Genton, P., Hirsch, E., Marescaux, C., Broglin, D., Bernasconi, R. (Eds.), Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. John Libbbey, London, pp. 415-422.
23. B receptor activation in absence seizures of lethargic (lh/lh) mice. Science. 257:1992;398-401.
24. B receptors regulate absence seizures in the lethargic (lh/lh) mouse model. J. Neurosci. 15:1995;7367-7376.
25. B Receptors in Mammalian Function. John Wiley and Sons, Chichester, pp. 349-365.
26. B receptor blocker CGP 35348. Neuroscience. 47:1992;63-68.
27. Kiessling M., Gass P. Immediate early gene expression in experimental epilepsy. Brain Pathol. 3:1993;381-393.
28. Knight A.R., Bowery N.G. GABA receptors in rats with spontaneous generalized nonconvulsive epilepsy. J. Neural Transm. Suppl. 35:1992;189-196.
29. B receptors in the lethargic (lh/lh) mouse model of absence epilepsy. Brain Res. 608:1993;101-106.
30. B receptor-mediated effects in synaptosomes of lethargic (lh/lh) mice. J. Neurochem. 65:1995;2087-2095.
31. B neurotransmission in the control of absence seizures in the rat. Neuroscience. 48:1992;87-93.
32. B receptors are involved in the occurrence of absence seizures in rats. Pharmacol. Commun. 2:1992;57-62.
33. B receptor antagonists: Potential new anti-absence drugs. J. Neural Transm. Suppl. 35:1992;179-188.
34. B-receptor binding sites in genetic absence epilepsy rats from Strasbourg (GAERS) and in non-epileptic control rats. In: Malafosse, A., Genton, P., Hirsch, E., Marescaux, C., Broglin, D., Bernasconi, R. (Eds.), Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. John Libbbey, London, pp. 177-185.
35. B receptors in GAERS compared to non-epileptic control rats using agonist and antagonist radioligands. Pharmacol. Rev. Commun. 8:1996;203-207.
36. A receptors. In: Enna, S.J., Bowery, N.G. (Eds.), The GABA Receptors. Humana Press Inc., Totowa, NJ, pp. 11-36.
37. B-receptor-mediated inhibition of the N-methyl-D-aspartate component of synaptic transmission in the rat hippocampus. J. Neurosci. 11:1991;203-209.
38. B Receptors in Mammalian Function. John Wiley and Sons, Chichester, pp. 197-205.
39. B tone' in vivo: The effect of CGP 35348 on long-term potentiation, paired-pulse inhibition and cortical excitability. Pharmacol. Commun. 2:1992;121.
40. B receptor antagonists on GABAergic transmission in vivo and in vitro. Eur. J. Pharmacol. 233:1993;179-186.
41. Paxinos, G., Watson, C., 1986. The rat brain in stereotaxic coordinates. Academic Press, New York.
42. B) receptor subtype. Brain Res. 604:1993;325-330.
43. B type Eur. J. Pharmacol. 144:1987;45-52.
44. Potier B., Dutar P. Presynaptic inhibitory effect of baclofen on hippocampal inhibitory synaptic transmission involves a pertussis toxin-sensitive G-protein. Eur. J. Pharmacol. 231:1993;427-433.
45. Richards D.A., Lemos T., Whitton P.S., Bowery N.G. Extracellular GABA in the ventrolateral thalamus of rats exhibiting spontaneous absence epilepsy: A microdialysis study. J. Neurochem. 65:1995;1674-1680.
46. B receptors in hippocampal epileptogenesis. Pharmacol. Commun. 2:1992;50.
47. B receptors in the generation of epileptiform activity in disinhibited hippocampal slice cultures. Neuroscience. 61:1994;823-832.
48. B-mediated mechanisms in experimental generalized absence seizures. Eur. J. Pharmacol. 213:1992;343-349.
49. Snead III, O.C., 1994. Pathophysiological mechanisms of experimental generalized absence seizures in rats. In: Malafosse, A., Genton, P., Hirsch, E., Marescaux, C., Broglin, D., Bernasconi, R. (Eds.), Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. John Libbbey, London, pp. 133-150.
50. B receptor action in the hippocampus. Pharmacol. Commun. 2:1992;41-46.
51. Vergnes, M., Marescaux, C., 1994. Pathophysiological mechanisms underlying genetic absence epilepsy in rats. In: Malafosse, A., Genton, P., Hirsch, E., Marescaux, C., Broglin, D., Bernasconi, R. (Eds.), Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. John Libbbey, London, pp. 151-168.
52. Vergnes M., Marescaux C., Micheletti G., Depaulis A., Rumbach L., Warter J.M. Enhancement of spike and wave discharges by GABAmimetic drugs in rats with spontaneous petit-mal-like epilepsy. Neurosci. Lett. 44:1984;91-94.
53. B receptor antagonists with similar potency: No evidence for pharmacologically different presynaptic receptors. Br. J. Pharmacol. 113:1994;1515-1521.